In the Ozempic era, not all pounds lost are met with praise. New research suggests that people may face more judgment for slimming down with the help of a GLP-1 drug than if they hadn’t lost weight at all. “We expected there might be some stigma around using a GLP-1,” Erin Standen, assistant professor of … Read more
America didn’t lose all its malls to the internet. It traded them in for Botox. Walk into any strip center worth its rent in 2025 and you’ll find the same thing: a med spa where the shoe store was and an IV drip lounge where the electronics store used to be. Now there’s data to … Read more
Medical innovation has really give people a shot at better heart health. About 805,000 people in the US have heart attacks every year, with one occurring every 40 seconds — and an alarming increase in those under 45. But new blockbuster medications that have taken the health world by storm could offer protection from adverse … Read more
Eau, eau, eau, Eau-zempic! You’ve heard of “Ozempic butt,” “Ozempic fingers,” “Ozempic mouth” and “Ozempic teeth” — now, there’s a new term to add to the GLP-1 lexicon: “Ozempic breath.” Bad breath is a common side effect of GLP-1 diabetes and weight loss drugs like Ozempic because they slow digestion, causing food to linger and … Read more
More than one in five Americans haven’t visited the optometrist in at least a year (22%) and another 15% “can’t remember” the last time they did so, according to new research. A survey of 2,000 U.S. adults looked at how respondents understand the importance of eye health and preventative care, finding that Gen Z is … Read more
Slimming down on a GLP-1 is one thing — keeping the pounds off after stopping the drug is another. But now, a groundbreaking new study suggests an experimental outpatient procedure may help prevent weight regain in patients no longer using the blockbuster diabetes and obesity meds. “As effective as GLP-1 medications are, many people stop … Read more
Your metabolism is no fool. Even if you initially lose weight on a certain diet or medication, to maintain those results, you have to constantly trick the metabolic system into letting you shed pounds. Otherwise, you might find yourself stuck at what obesity doctors call the “weight loss plateau.” This phenomenon is extremely common among … Read more
The exploding popularity of GLP-1 receptor agonists like Ozempic and Wegovy is often hailed as a public health triumph, but one potential side effect may be flying under the radar. The risk of divorce increases as weight drops, according to historical data from bariatric surgery patients. Some experts believe that the same pattern could occur as … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. You lost the weight… now what? That’s the question Kourtney Kardashian-Barker’s women’s supplement brand was aiming to answer with its latest launch. The company just unveiled Lemme Metabolism, daily capsules … Read more
Just think, we may have never gotten the “Oh, oh, oh, Ozempic!” jingle stuck in our heads if it wasn’t for a creepy, bottom-dwelling fish. Dr. Joel Habener of Massachusetts General Hospital unexpectedly discovered GLP-1 in the 1980s while analyzing the pancreatic genes in anglerfish. Habener’s team identified the precursor to GLP-1, a hormone that regulates … Read more
*Gulp* Much to the relief of the needle-shy, the FDA has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, from pharma giant Eli Lilly, promises to be even more convenient than its predecessor with similar, if slightly less drastic, weight-trimming results. The … Read more
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight loss. Known as “triple-G,” injectable retatrutide levies a triple whammy on the GLP-1, GIP and glucagon hormones, whereas most other drugs on the market only mimic one or two of those hormones. Eli Lilly’s new retatrutide drug … Read more
Weight loss is complex – and goes beyond counting calories, according to experts. Dr. Jason Fung, a kidney specialist and author of the recent book “The Hunger Code,” said lasting weight loss requires a shift in how people understand and respond to hunger. “Most of the time, we focus on eating less or what we’re eating, … Read more
The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long-term weight loss maintenance for adult patients. It is triple the previous maximum dose of 2.4 mg. This marks the fourth approval in the FDA’s National … Read more
Indiana Jones’ greatest fear may be obesity’s biggest enemy. Scientists at three universities have turned to nature to find a property that rivals the benefits of GLP-1 drugs without the laundry list of side effects. What they’ve discovered, in the cold blood of a creature that grows up to 33 feet long, is poised to … Read more
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop pounds, they drop out. Pharmaceutical manufacturers are reporting widespread instances of patients quitting their clinical trials prematurely once they realize they’ve been … Read more
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several other countries set to follow in the months ahead. The move is expected to unleash a wave of cheaper alternatives, dramatically widening … Read more
Welcome to The Thin Line, the New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Magic pills promising to help overweight people slim down are nothing new. When I was a teenager on Staten Island, back when ephedra was still legal, I bought a bottle … Read more
Downside to dropping pounds? The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side effects. Historically, semaglutide, the active ingredient in Ozempic and Wegovy, has been administered via weekly injections into the fatty tissue just under the skin of the stomach, thigh or upper arm. But due to consumer … Read more